Evandro de Azambuja, President of the Belgian Society of Medical Oncology (BSMO) for 2023-2026, shared a post on LinkedIn about a paper he co-authored with colleagues published in Clinical Breast Cancer:
“Diversity in clinical trials: our analysis shows that despite the younger age and more aggressive BC, survival outcomes in patients of Maghreb vs. non-Maghreb origin did not differ. These results underscore the importance of considering ethnic minority populations to develop tailored prevention strategies and improve their inclusion in clinical trials.”
Title: Characteristics, treatment patterns and clinical outcomes of women with Maghreb origin and diagnosis of breast cancer: a single-center, retrospective cohort study
Authors: Chiara Dauccia, Diogo Martins-Branco, Michel Moreau, Lieveke Ameye, Elisa Agostinetto, Luca Arecco, Soraia Lobo-Martins, Anja Skoporc, Isabel Vilas-Boas, Masa Auprih, Ahmad Awada, Véronique Debien, Evandro de Azambuja
You can read the Full Article in Clinical Breast Cancer.
More posts featuring Evandro de Azambuja.